ID   LATS1_HUMAN             Reviewed;        1130 AA.
AC   O95835; Q6PKD0;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   02-NOV-2010, entry version 100.
DE   RecName: Full=Serine/threonine-protein kinase LATS1;
DE            EC=2.7.11.1;
DE   AltName: Full=Large tumor suppressor homolog 1;
DE   AltName: Full=WARTS protein kinase;
DE            Short=h-warts;
GN   Name=LATS1; Synonyms=WARTS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION, AND
RP   INTERACTION WITH CDK1.
RC   TISSUE=Fetal brain;
RX   MEDLINE=99140767; PubMed=9988268; DOI=10.1038/5960;
RA   Tao W., Zhang S., Turenchalk G.S., Stewart R.A., St John M.A.,
RA   Chen W., Xu T.;
RT   "Human homologue of the Drosophila melanogaster lats tumour suppressor
RT   modulates CDC2 activity.";
RL   Nat. Genet. 21:177-181(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RX   MEDLINE=99447636; PubMed=10518011; DOI=10.1016/S0014-5793(99)01224-7;
RA   Nishiyama Y., Hirota T., Morisaki T., Hara T., Marumoto T., Iida S.,
RA   Makino K., Yamamoto H., Hiraoka T., Kitamura N., Saya H.;
RT   "A human homolog of Drosophila warts tumor suppressor, h-warts,
RT   localized to mitotic apparatus and specifically phosphorylated during
RT   mitosis.";
RL   FEBS Lett. 459:159-165(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endometrium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH ZYX.
RX   MEDLINE=20293204; PubMed=10831611; DOI=10.1083/jcb.149.5.1073;
RA   Hirota T., Morisaki T., Nishiyama Y., Marumoto T., Tada K., Hara T.,
RA   Masuko N., Inagaki M., Hatakeyama K., Saya H.;
RT   "Zyxin, a regulator of actin filament assembly, targets the mitotic
RT   apparatus by interacting with h-warts/LATS1 tumor suppressor.";
RL   J. Cell Biol. 149:1073-1086(2000).
RN   [5]
RP   FUNCTION, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-734.
RX   PubMed=15122335; DOI=10.1038/sj.onc.1207623;
RA   Iida S., Hirota T., Morisaki T., Marumoto T., Hara T., Kuninaka S.,
RA   Honda S., Kosai K., Kawasuji M., Pallas D.C., Saya H.;
RT   "Tumor suppressor WARTS ensures genomic integrity by regulating both
RT   mitotic progression and G1 tetraploidy checkpoint function.";
RL   Oncogene 23:5266-5274(2004).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH LIMK1.
RX   PubMed=15220930; DOI=10.1038/ncb1140;
RA   Yang X., Yu K., Hao Y., Li D.-M., Stewart R.A., Insogna K.L., Xu T.;
RT   "LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.";
RL   Nat. Cell Biol. 6:609-617(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [8]
RP   PHOSPHORYLATION AT SER-909 AND THR-1079.
RX   PubMed=15688006; DOI=10.1038/sj.onc.1208445;
RA   Chan E.H.Y., Nousiainen M., Chalamalasetty R.B., Schaefer A.,
RA   Nigg E.A., Sillje H.H.W.;
RT   "The Ste20-like kinase Mst2 activates the human large tumor suppressor
RT   kinase Lats1.";
RL   Oncogene 24:2076-2086(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-277, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17053785; DOI=10.1038/sj.emboj.7601384;
RA   Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,
RA   Lottspeich F., Chen Z.;
RT   "Tyrosine phosphorylated Par3 regulates epithelial tight junction
RT   assembly promoted by EGFR signaling.";
RL   EMBO J. 25:5058-5070(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-674, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   FUNCTION, INTERACTION WITH YAP1, AND MUTAGENESIS OF TYR-559.
RX   PubMed=18158288; DOI=10.1074/jbc.M709037200;
RA   Hao Y., Chun A., Cheung K., Rashidi B., Yang X.;
RT   "Tumor suppressor LATS1 is a negative regulator of oncogene YAP.";
RL   J. Biol. Chem. 283:5496-5509(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-246; SER-464 AND
RP   SER-613, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-246; SER-278 AND
RP   SER-464, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; THR-246 AND
RP   SER-464, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; THR-246; THR-261;
RP   SER-462; SER-464; THR-612 AND SER-613, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   INTERACTION WITH MOBKL1A AND MOBKL1B.
RX   PubMed=19739119; DOI=10.1002/ijc.24878;
RA   Chow A., Hao Y., Yang X.;
RT   "Molecular characterization of human homologs of yeast MOB1.";
RL   Int. J. Cancer 126:2079-2089(2010).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-96; GLY-204; GLN-237; TRP-370;
RP   SER-531; LEU-641; ILE-669; PRO-806 AND SER-1000.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Negative regulator of YAP1 in the Hippo signaling
CC       pathway that plays a pivotal role in organ size control and tumor
CC       suppression by restricting proliferation and promoting apoptosis.
CC       The core of this pathway is composed of a kinase cascade wherein
CC       MST1/MST2, in complex with its regulatory protein SAV1,
CC       phosphorylates and activates LATS1/2 in complex with its
CC       regulatory protein MOB1, which in turn phosphorylates and
CC       inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of
CC       YAP1 by LATS1 inhibits its translocation into the nucleus to
CC       regulate cellular genes important for cell proliferation, cell
CC       death, and cell migration. Acts as a tumor suppressor which plays
CC       a critical role in maintenance of ploidy through its actions in
CC       both mitotic progression and the G1 tetraploidy checkpoint.
CC       Negatively regulates G2/M transition by down-regulating CDK1
CC       kinase activity. Involved in the control of p53 expression.
CC       Affects cytokinesis by regulating actin polymerization through
CC       negative modulation of LIMK1. May also play a role in endocrine
CC       function.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Complexes with CDK1 in early mitosis. LATS1-associated
CC       CDK1 has no mitotic cyclin partner and no apparent kinase
CC       activity. Binds phosphorylated ZYX, locating this protein to the
CC       mitotic spindle and suggesting a role for actin regulatory
CC       proteins during mitosis. Binds to and colocalizes with LIMK1 at
CC       the actomyosin contractile ring during cytokinesis. Interacts (via
CC       PPxY motif 2) with YAP1 (via WW domains). Interacts with MOBKL1A
CC       and MOBKL1B.
CC   -!- INTERACTION:
CC       P06493:CDC2; NbExp=1; IntAct=EBI-444209, EBI-444308;
CC       P53667:LIMK1; NbExp=3; IntAct=EBI-444209, EBI-444403;
CC       Q15942:ZYX; NbExp=3; IntAct=EBI-444209, EBI-444225;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, centrosome.
CC       Note=Localizes to the centrosomes throughout interphase but
CC       migrates to the mitotic apparatus, including spindle pole bodies,
CC       mitotic spindle, and midbody, during mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95835-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95835-2; Sequence=VSP_051604, VSP_051605;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in all adult tissues examined except
CC       for lung and kidney.
CC   -!- PTM: Autophosphorylated and phosphorylated during M-phase of the
CC       cell cycle. Phosphorylated by STK3 at Ser-909 and Thr-1079, which
CC       results in its activation. Phosphorylated upon DNA damage,
CC       probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF104413; AAD16882.1; -; mRNA.
DR   EMBL; AF164041; AAD50272.1; -; mRNA.
DR   EMBL; BC002767; AAH02767.1; -; mRNA.
DR   IPI; IPI00005858; -.
DR   IPI; IPI00470672; -.
DR   RefSeq; NP_004681.1; -.
DR   UniGene; Hs.716697; -.
DR   ProteinModelPortal; O95835; -.
DR   SMR; O95835; 95-146, 689-1045.
DR   IntAct; O95835; 18.
DR   STRING; O95835; -.
DR   PhosphoSite; O95835; -.
DR   PRIDE; O95835; -.
DR   Ensembl; ENST00000253339; ENSP00000253339; ENSG00000131023.
DR   GeneID; 9113; -.
DR   KEGG; hsa:9113; -.
DR   UCSC; uc003qmu.1; human.
DR   UCSC; uc003qmw.2; human.
DR   CTD; 9113; -.
DR   GeneCards; GC06M149982; -.
DR   GeneCards; GC06M150023; -.
DR   H-InvDB; HIX0200897; -.
DR   HGNC; HGNC:6514; LATS1.
DR   HPA; HPA031804; -.
DR   MIM; 603473; gene.
DR   PharmGKB; PA30301; -.
DR   eggNOG; prNOG13853; -.
DR   HOGENOM; HBG447077; -.
DR   HOVERGEN; HBG052311; -.
DR   InParanoid; O95835; -.
DR   OMA; QVRSVTP; -.
DR   OrthoDB; EOG9V722C; -.
DR   PhylomeDB; O95835; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 34157; -.
DR   ArrayExpress; O95835; -.
DR   Bgee; O95835; -.
DR   CleanEx; HS_LATS1; -.
DR   Genevestigator; O95835; -.
DR   GermOnline; ENSG00000131023; Homo sapiens.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IMP:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0035329; P:hippo signaling cascade; IDA:BHF-UCL.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007067; P:mitosis; IEA:UniProtKB-KW.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt recept...; IMP:BHF-UCL.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent pro...; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phos...; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0000819; P:sister chromatid segregation; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR009060; UBA-like.
DR   InterPro; IPR000449; UBA/transl_elong_EF1B_N.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   Pfam; PF00627; UBA; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF46934; UBA_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Metal-binding; Mitosis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase;
KW   Tumor suppressor.
FT   CHAIN         1   1130       Serine/threonine-protein kinase LATS1.
FT                                /FTId=PRO_0000086232.
FT   DOMAIN      100    141       UBA.
FT   DOMAIN      705   1010       Protein kinase.
FT   DOMAIN     1011   1090       AGC-kinase C-terminal.
FT   NP_BIND     711    719       ATP (By similarity).
FT   REGION      526    655       Interaction with YAP1.
FT   MOTIF       373    376       PPxY motif 1.
FT   MOTIF       556    559       PPxY motif 2.
FT   ACT_SITE    828    828       Proton acceptor (By similarity).
FT   BINDING     734    734       ATP.
FT   MOD_RES     181    181       Phosphoserine.
FT   MOD_RES     244    244       Phosphoserine.
FT   MOD_RES     246    246       Phosphothreonine.
FT   MOD_RES     261    261       Phosphothreonine.
FT   MOD_RES     277    277       Phosphotyrosine.
FT   MOD_RES     278    278       Phosphoserine.
FT   MOD_RES     462    462       Phosphoserine.
FT   MOD_RES     464    464       Phosphoserine.
FT   MOD_RES     612    612       Phosphothreonine.
FT   MOD_RES     613    613       Phosphoserine.
FT   MOD_RES     674    674       Phosphoserine.
FT   MOD_RES     909    909       Phosphoserine; by STK3.
FT   MOD_RES    1079   1079       Phosphothreonine; by STK3.
FT   VAR_SEQ     672    690       GLSQDAQDQMRKMLCQKES -> KPFKMSIFILNHLFAWCL
FT                                F (in isoform 2).
FT                                /FTId=VSP_051604.
FT   VAR_SEQ     691   1130       Missing (in isoform 2).
FT                                /FTId=VSP_051605.
FT   VARIANT      96     96       R -> W (in dbSNP:rs55945045).
FT                                /FTId=VAR_040660.
FT   VARIANT     204    204       S -> G (in dbSNP:rs34793526).
FT                                /FTId=VAR_040661.
FT   VARIANT     237    237       P -> Q (in dbSNP:rs56149740).
FT                                /FTId=VAR_040662.
FT   VARIANT     370    370       R -> W (in dbSNP:rs56348064).
FT                                /FTId=VAR_040663.
FT   VARIANT     531    531       P -> S (in dbSNP:rs55874734).
FT                                /FTId=VAR_040664.
FT   VARIANT     641    641       F -> L (in dbSNP:rs35163691).
FT                                /FTId=VAR_040665.
FT   VARIANT     669    669       M -> I (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040666.
FT   VARIANT     806    806       R -> P (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040667.
FT   VARIANT    1000   1000       G -> S (in dbSNP:rs56412005).
FT                                /FTId=VAR_040668.
FT   MUTAGEN     559    559       Y->F: Loss of interaction with YAP1.
FT   MUTAGEN     734    734       K->A: Loss of kinase activity,
FT                                autophosphorylation, increased ploidy,
FT                                prolonged duration of mitosis and lack of
FT                                p53 expression.
SQ   SEQUENCE   1130 AA;  126870 MW;  11CFBCD8FD87DCD8 CRC64;
     MKRSEKPEGY RQMRPKTFPA SNYTVSSRQM LQEIRESLRN LSKPSDAAKA EHNMSKMSTE
     DPRQVRNPPK FGTHHKALQE IRNSLLPFAN ETNSSRSTSE VNPQMLQDLQ AAGFDEDMVI
     QALQKTNNRS IEAAIEFISK MSYQDPRREQ MAAAAARPIN ASMKPGNVQQ SVNRKQSWKG
     SKESLVPQRH GPPLGESVAY HSESPNSQTD VGRPLSGSGI SAFVQAHPSN GQRVNPPPPP
     QVRSVTPPPP PRGQTPPPRG TTPPPPSWEP NSQTKRYSGN MEYVISRISP VPPGAWQEGY
     PPPPLNTSPM NPPNQGQRGI SSVPVGRQPI IMQSSSKFNF PSGRPGMQNG TGQTDFMIHQ
     NVVPAGTVNR QPPPPYPLTA ANGQSPSALQ TGGSAAPSSY TNGSIPQSMM VPNRNSHNME
     LYNISVPGLQ TNWPQSSSAP AQSSPSSGHE IPTWQPNIPV RSNSFNNPLG NRASHSANSQ
     PSATTVTAIT PAPIQQPVKS MRVLKPELQT ALAPTHPSWI PQPIQTVQPS PFPEGTASNV
     TVMPPVAEAP NYQGPPPPYP KHLLHQNPSV PPYESISKPS KEDQPSLPKE DESEKSYENV
     DSGDKEKKQI TTSPITVRKN KKDEERRESR IQSYSPQAFK FFMEQHVENV LKSHQQRLHR
     KKQLENEMMR VGLSQDAQDQ MRKMLCQKES NYIRLKRAKM DKSMFVKIKT LGIGAFGEVC
     LARKVDTKAL YATKTLRKKD VLLRNQVAHV KAERDILAEA DNEWVVRLYY SFQDKDNLYF
     VMDYIPGGDM MSLLIRMGIF PESLARFYIA ELTCAVESVH KMGFIHRDIK PDNILIDRDG
     HIKLTDFGLC TGFRWTHDSK YYQSGDHPRQ DSMDFSNEWG DPSSCRCGDR LKPLERRAAR
     QHQRCLAHSL VGTPNYIAPE VLLRTGYTQL CDWWSVGVIL FEMLVGQPPF LAQTPLETQM
     KVINWQTSLH IPPQAKLSPE ASDLIIKLCR GPEDRLGKNG ADEIKAHPFF KTIDFSSDLR
     QQSASYIPKI THPTDTSNFD PVDPDKLWSD DNEEENVNDT LNGWYKNGKH PEHAFYEFTF
     RRFFDDNGYP YNYPKPIEYE YINSQGSEQQ SDEDDQNTGS EIKNRDLVYV
//
